Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ: HRTS) stock price, news, charts, stock research, profile.
Open | $34.88 |
High | $35.35 |
52 Wk High | $36.03 |
AUM | 67.50M |
Dividend | - |
Ex-Div Date | - |
Volume | 32.28K |
Market Cap | $64.23B |
Mgmt Fee | 0.99% |
P/E Ratio | 37.15 |
Prev. Close | $34.74 |
Low | $34.88 |
52 Wk Low | $26.26 |
Shares Out | - |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | - |
Beta | - |
Avg. Expense Ratio | 0.75% |
P/B Ratio | 5.29 |
You can purchase shares of Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS) through any online brokerage.
There are no as such competitors for Tema GLP-1, Obesity & Cardiometabolic ETF.
There is no analysis for Tema GLP-1, Obesity & Cardiometabolic ETF to provide a consensus price target.
The stock price for Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ: HRTS) is $35.08 last updated August 23, 2024 at 4:15 PM EDT.
There are no upcoming dividends for Tema GLP-1, Obesity & Cardiometabolic ETF.
Tema GLP-1, Obesity & Cardiometabolic ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Tema GLP-1, Obesity & Cardiometabolic ETF.
Sector | Healthcare |
Category | - |
Investment Style | Large Cap Blend |
Fund Inception | Nov 20, 2023 |
Managers | Ryan Houlton Troy Cates Garrett Paolella Yuri Khodjamirian David Song |
Definition | - |